0: ANTIRETROVIRAL THERAPY STATUS
1: ARVs RECOMMENDED FOR PEP
2: COMPLETED
3: DAYS ON POST EXPOSURE PROPHYLAXIS BEFORE STOPPING DUE TO NON-ADHERENCE, ANTIRETROVIRALS
4: DAYS ON POST EXPOSURE PROPHYLAXIS BEFORE STOPPING DUE TO SIDE EFFECTS, ANTIRETROVIRALS
5: LOPINAVIR AND RITONAVIR
6: ON ANTIRETROVIRAL THERAPY
7: PATIENT REFUSAL
8: REASON ANTIRETROVIRALS STOPPED
9: ZIDOVUDINE AND LAMIVUDINE
0::6
...0::6
0: ANTIRETROVIRAL THERAPY STATUS
1: ARVs RECOMMENDED FOR PEP
2: COMPLETED
3: DAYS ON POST EXPOSURE PROPHYLAXIS BEFORE STOPPING DUE TO NON-ADHERENCE, ANTIRETROVIRALS
4: DAYS ON POST EXPOSURE PROPHYLAXIS BEFORE STOPPING DUE TO SIDE EFFECTS, ANTIRETROVIRALS
5: LOPINAVIR AND RITONAVIR
6: ON ANTIRETROVIRAL THERAPY
7: PATIENT REFUSAL
8: REASON ANTIRETROVIRALS STOPPED
9: ZIDOVUDINE AND LAMIVUDINE
1::9
...0::6
0: ANTIRETROVIRAL THERAPY STATUS
1: ARVs RECOMMENDED FOR PEP
2: COMPLETED
3: DAYS ON POST EXPOSURE PROPHYLAXIS BEFORE STOPPING DUE TO NON-ADHERENCE, ANTIRETROVIRALS
4: DAYS ON POST EXPOSURE PROPHYLAXIS BEFORE STOPPING DUE TO SIDE EFFECTS, ANTIRETROVIRALS
5: LOPINAVIR AND RITONAVIR
6: ON ANTIRETROVIRAL THERAPY
7: PATIENT REFUSAL
8: REASON ANTIRETROVIRALS STOPPED
9: ZIDOVUDINE AND LAMIVUDINE
1::5
...0::6
0: ANTIRETROVIRAL THERAPY STATUS
1: ARVs RECOMMENDED FOR PEP
2: COMPLETED
3: DAYS ON POST EXPOSURE PROPHYLAXIS BEFORE STOPPING DUE TO NON-ADHERENCE, ANTIRETROVIRALS
4: DAYS ON POST EXPOSURE PROPHYLAXIS BEFORE STOPPING DUE TO SIDE EFFECTS, ANTIRETROVIRALS
5: LOPINAVIR AND RITONAVIR
6: ON ANTIRETROVIRAL THERAPY
7: PATIENT REFUSAL
8: REASON ANTIRETROVIRALS STOPPED
9: ZIDOVUDINE AND LAMIVUDINE
8::7
...0::6